BioRestorative Therapies (BRTX) Securities (2022 - 2025)
BioRestorative Therapies' (BRTX) quarterly Securities came in at $1.4 million in Q4 2025, down 85.84% YoY from $10.2 million in Q4 2024, and down 85.84% on a QoQ basis from $10.2 million in Q4 2024.
BioRestorative Therapies (BRTX) Securities (2022 - 2025) Analysis & Trends
BioRestorative Therapies (BRTX) has 4 years of Securities data on file, last reported at $1.4 million in Q4 2025.
- Quarterly Securities fell 85.84% year-over-year to $1.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.4 million (down 85.84% YoY) and the FY2025 annual result came in at $1.4 million, down 85.84% from the prior year.
- Securities retreated to $1.4 million in Q4 2025, from $10.2 million in the prior quarter.
- In the past five years, Securities ranged from a high of $13.0 million in Q4 2022 to a low of $1.4 million in Q4 2025.
- A 4-year average of $8.7 million and a median of $10.2 million in 2023 frame the typical range for Securities.
- Annual changes were most pronounced in 2024 — Securities advanced 0.03% — and 2025, when it slumped 85.84%.
- Tracing BRTX's Securities over 4 years: stood at $13.0 million in 2022, then retreated by 21.89% to $10.2 million in 2023, then increased by 0.03% to $10.2 million in 2024, then slumped by 85.84% to $1.4 million in 2025.
- The last three Securities figures came in at $1.4 million (Q4 2025), $10.2 million (Q4 2024), and $10.2 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Securities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | BioRestorative Therapies | 2.00 Mn | -953,752.60 | 17,964.00 | 1.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.44 Mn |
| Dec 31, 2024 | 10.18 Mn |
| Dec 31, 2023 | 10.18 Mn |
| Dec 31, 2022 | 13.04 Mn |